Cargando…
Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
BACKGROUND: Thymosin family genes (TMSs), biologically important peptides with diverse intracellular and extracellular functions, have been shown to promote the progression of multiple cancers. However, multiomics characterization of TMSs and their role in human cancer prognosis has not been systema...
Autores principales: | Xiong, Ye, Qi, Yanhua, Pan, Ziwen, Wang, Shaobo, Li, Boyan, Feng, Bowen, Xue, Hao, Zhao, Rongrong, Li, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513945/ https://www.ncbi.nlm.nih.gov/pubmed/36163046 http://dx.doi.org/10.1186/s12935-022-02698-5 |
Ejemplares similares
-
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
por: Darb-Esfahani, S, et al.
Publicado: (2012) -
The Clinical Relevance and Functional Implications of Thymosin Beta-10 in Glioma
por: Li, Weimin, et al.
Publicado: (2023) -
CCNF is a potential pancancer biomarker and immunotherapy target
por: Wei, Lifang, et al.
Publicado: (2023) -
Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy
por: Zhao, Rongrong, et al.
Publicado: (2022) -
Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway
por: Inoue, Miki, et al.
Publicado: (2022)